Amylyx Pharmaceuticals, Inc. (AMLX:NASDAQ) closed at $27.65 on October 15, 2026, up 2.29% on the day. The stock trades 32.8% below its 52-week high of $41.14 and 155.3% above its 52-week low of $10.83. Over the past year, it gained 82.3%. Amylyx Pharmaceuticals, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +0.62% | -15.26% | +58.45% | +57.37% | +82.27% |
In 252 trading sessions since October 15, 2025, AMLX closed higher on 116 days (46%). Its best day was August 18, 2026 (+63.84%) and its worst was March 3, 2026 (-7.78%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 1 time.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Find more stocks like AMLX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.